Upload
others
View
6
Download
0
Embed Size (px)
Citation preview
ORIGINAL RESEARCH
Meta-analysis of Genome-Wide Association Studiesfor Extraversion: Findings from the Genetics of PersonalityConsortium
Stephanie M. van den Berg1• Marleen H. M. de Moor2,3,4
• Karin J. H. Verweij5,6•
Robert F. Krueger7• Michelle Luciano8,9
• Alejandro Arias Vasquez10,11,12,13•
Lindsay K. Matteson7• Jaime Derringer14
• Tonu Esko15• Najaf Amin16
•
Scott D. Gordon5• Narelle K. Hansell5 • Amy B. Hart17
• Ilkka Seppala18•
Jennifer E. Huffman19• Bettina Konte20
• Jari Lahti21,22• Minyoung Lee23
•
Mike Miller7• Teresa Nutile24
• Toshiko Tanaka25• Alexander Teumer26
•
Alexander Viktorin27• Juho Wedenoja28
• Abdel Abdellaoui2 • Goncalo R. Abecasis29•
Daniel E. Adkins30• Arpana Agrawal31
• Juri Allik32,33• Katja Appel34
•
Timothy B. Bigdeli23• Fabio Busonero35
• Harry Campbell36• Paul T. Costa37
•
George Davey Smith38• Gail Davies8,9
• Harriet de Wit39• Jun Ding67
•
Barbara E. Engelhardt40• Johan G. Eriksson22,41,42,43,44
• Iryna O. Fedko2•
Luigi Ferrucci25• Barbara Franke10,11,12
• Ina Giegling20• Richard Grucza31
•
Annette M. Hartmann20• Andrew C. Heath31
• Kati Heinonen21• Anjali K. Henders5
•
Georg Homuth45• Jouke-Jan Hottenga2
• William G. Iacono7• Joost Janzing11
•
Markus Jokela21• Robert Karlsson27
• John P. Kemp38,46• Matthew G. Kirkpatrick39
•
Antti Latvala41,28• Terho Lehtimaki18
• David C. Liewald8,9• Pamela A. F. Madden31
•
Chiara Magri47• Patrik K. E. Magnusson27
• Jonathan Marten19• Andrea Maschio35
•
Hamdi Mbarek2• Sarah E. Medland5
• Evelin Mihailov15,48• Yuri Milaneschi49
•
Edited by Stacey Cherny.
Stephanie M. van den Berg and Marleen H. M. de Moor shared first
authorship.
Electronic supplementary material The online version of thisarticle (doi:10.1007/s10519-015-9735-5) contains supplementarymaterial, which is available to authorized users.
& Stephanie M. van den Berg
1 Department of Research Methodology, Measurement and
Data-Analysis (OMD), Faculty of Behavioural, Management,
and Social Sciences, University of Twente, PO Box 217,
7500 AE Enschede, The Netherlands
2 Department of Biological Psychology, VU University
Amsterdam, Amsterdam, The Netherlands
3 Department of Clinical Child and Family Studies, VU
University Amsterdam, Amsterdam, The Netherlands
4 Department of Methods, VU University Amsterdam,
Amsterdam, The Netherlands
5 QIMR Berghofer Medical Research Institute, Brisbane,
Australia
6 Department of Developmental Psychology and EMGO
Institute for Health and Care Research, VU University
Amsterdam, Amsterdam, The Netherlands
7 Department of Psychology, University of Minnesota,
Minneapolis, USA
8 Department of Psychology, University of Edinburgh,
Edinburgh, UK
9 Centre for Cognitive Ageing and Cognitive Epidemiology,
University of Edinburgh, Edinburgh, UK
10 Donders Institute for Cognitive Neuroscience, Radboud
University Nijmegen, Nijmegen, The Netherlands
11 Department of Psychiatry, Radboud University Nijmegen
Medical Center, Nijmegen, The Netherlands
12 Department of Human Genetics, Radboud University
Nijmegen Medical Center, Nijmegen, The Netherlands
13 Department of Cognitive Neuroscience, Radboud University
Nijmegen Medical Center, Nijmegen, The Netherlands
14 Department of Psychology, University of Illinois at Urbana-
Champaign, Champaign, IL, USA
15 Estonian Genome Center, University of Tartu, Tartu, Estonia
123
Behav Genet (2016) 46:170–182
DOI 10.1007/s10519-015-9735-5
Grant W. Montgomery5• Matthias Nauck50
• Michel G. Nivard2• Klaasjan G. Ouwens2
•
Aarno Palotie51,52• Erik Pettersson27
• Ozren Polasek53• Yong Qian67
•
Laura Pulkki-Raback21• Olli T. Raitakari54,55
• Anu Realo32• Richard J. Rose56
•
Daniela Ruggiero24• Carsten O. Schmidt26
• Wendy S. Slutske57• Rossella Sorice24
•
John M. Starr9,58• Beate St Pourcain38,59,60
• Angelina R. Sutin25,61•
Nicholas J. Timpson38• Holly Trochet19
• Sita Vermeulen12,62• Eero Vuoksimaa28
•
Elisabeth Widen52• Jasper Wouda1,2
• Margaret J. Wright5• Lina Zgaga36,63
•
Generation Scotland64• David Porteous65
• Alessandra Minelli47•
Abraham A. Palmer17,39• Dan Rujescu20
• Marina Ciullo24• Caroline Hayward19
•
Igor Rudan36• Andres Metspalu15,33
• Jaakko Kaprio41,28,52• Ian J. Deary8,9
•
Katri Raikkonen21• James F. Wilson19,36
• Liisa Keltikangas-Jarvinen21•
Laura J. Bierut31• John M. Hettema23
• Hans J. Grabe34,66• Brenda W. J. H. Penninx49
•
Cornelia M. van Duijn16• David M. Evans38
• David Schlessinger67•
Nancy L. Pedersen27• Antonio Terracciano22,25
• Matt McGue7,68•
Nicholas G. Martin5• Dorret I. Boomsma2
Received: 30 October 2014 / Accepted: 10 August 2015 / Published online: 11 September 2015
� The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract Extraversion is a relatively stable and heritable
personality trait associated with numerous psychosocial,
lifestyle and health outcomes. Despite its substantial heri-
tability, no genetic variants have been detected in previous
genome-wide association (GWA) studies, which may be
due to relatively small sample sizes of those studies. Here,
we report on a large meta-analysis of GWA studies for
extraversion in 63,030 subjects in 29 cohorts. Extraversion
item data from multiple personality inventories were har-
monized across inventories and cohorts. No genome-wide
significant associations were found at the single nucleotide
polymorphism (SNP) level but there was one significant hit
at the gene level for a long non-coding RNA site
(LOC101928162). Genome-wide complex trait analysis in
two large cohorts showed that the additive variance
explained by common SNPs was not significantly different
16 Department of Epidemiology, Erasmus University Medical
Center, Rotterdam, The Netherlands
17 Department of Human Genetics, University of Chicago,
Chicago, IL, USA
18 Department of Clinical Chemistry, Fimlab Laboratories and
School of Medicine, University of Tampere, Tampere,
Finland
19 MRC Human Genetics Unit, MRC IGMM, Western General
Hospital, University of Edinburgh, Edinburgh, UK
20 Department of Psychiatry, University of Halle, Halle,
Germany
21 Institute of Behavioural Sciences, University of Helsinki,
Helsinki, Finland
22 Folkhalsan Research Center, Helsinki, Finland
23 Department of Psychiatry, Virginia Institute for Psychiatric
and Behavioral Genetics, Virginia Commonwealth
University, Richmond, VA, USA
24 Institute of Genetics and Biophysics ‘‘A. Buzzati-Traverso’’ –
CNR, Naples, Italy
25 National Institute on Aging, NIH, Baltimore, MD, USA
26 Institute for Community Medicine, University Medicine
Greifswald, Greifswald, Germany
27 Department of Medical Epidemiology and Biostatistics,
Karolinska Institutet, Stockholm, Sweden
28 Department of Public Health, University of Helsinki,
Helsinki, Finland
29 Department of Biostatistics, Center for Statistical Genetics,
University of Michigan School of Public Health, Ann Arbor,
MI, USA
30 Pharmacotherapy & Outcomes Science, Virginia
Commonwealth University, Richmond, VA, USA
31 Department of Psychiatry, Washington University School of
Medicine, St. Louis, MO, USA
32 Department of Psychology, University of Tartu, Tartu,
Estonia
33 Estonian Academy of Sciences, Tallinn, Estonia
34 Department of Psychiatry and Psychotherapy, University
Medicine Greifswald, Greifswald, Germany
35 Istituto di Ricerca Genetica e Biomedica (IRGB), CNR,
Monserrato, Italy
36 Usher Institute for Population Health Sciences and
Informatics, University of Edinburgh, Edinburgh, UK
37 Behavioral Medicine Research Center, Duke University
School of Medicine, Durham, NC, USA
38 Medical Research Council Integrative Epidemiology Unit,
School of Social and Community Medicine, University of
Bristol, Bristol, UK
Behav Genet (2016) 46:170–182 171
123
from zero, but polygenic risk scores, weighted using link-
age information, significantly predicted extraversion scores
in an independent cohort. These results show that
extraversion is a highly polygenic personality trait, with an
architecture possibly different from other complex human
traits, including other personality traits. Future studies are
required to further determine which genetic variants, by
what modes of gene action, constitute the heritable nature
of extraversion.
Keywords Personality � Phenotype harmonization �Common genetic variants � Imputation � Polygenic risk
Introduction
Extraversion is a personality trait characterized by the
tendency to experience positive emotions, to be active and
feel energetic, to be talkative and to enjoy social interac-
tions. Extraversion is associated with numerous psy-
chosocial, lifestyle and health outcomes, such as academic
and job performance, well-being, obesity, substance use,
physical activity, bipolar disorder, borderline personality
disorder, Alzheimer’s disease, and longevity (De Moor
et al. 2006, 2011; Distel et al. 2009a; Furnham et al. 2013;
Judge et al. 2013; Middeldorp et al. 2011; Rhodes and
Smith 2006; Sutin et al. 2011; Terracciano et al. 2008;
Terracciano et al. 2014; Weiss et al. 2008).
Extraversion can be measured with multiple inventories
that have been developed as part of different personality
theories. For example, extraversion is one of the five per-
sonality domains as assessed with the Neuroticism–Ex-
traversion–Openness to Experience (NEO) personality
inventories (Costa and McCrae 1992). Extraversion is also
included in Eysenck’s three-dimensional theory of per-
sonality (Eysenck and Eysenck 1964, 1975; Eysenck et al.
1985). In Cloninger’s theory on temperaments and char-
acters (Cloninger 1987; Cloninger et al. 1993), Harm
Avoidance, Novelty Seeking and Reward Dependence are
related to extraversion (De Fruyt et al. 2000). Tellegen’s
personality theory posits the higher order domain of Posi-
tive Emotionality (Patrick et al. 2002), which resembles
and is highly correlated with extraversion (Church 1994).
We showed recently, by performing an Item Response
Theory (IRT) analysis using test linking (Kolen and
Brennan 2004), that item data on Extraversion, Reward
dependence and Positive Emotionality can be harmonized
to broadly assess the same underlying extraversion con-
struct (van den Berg et al. 2014). This harmonization was
performed in over 160,000 individuals from 23 cohorts
participating in the Genetics of Personality Consortium
(GPC). Briefly, harmonization was carried out in each
cohort separately by first fitting an IRT model to data from
39 Department of Psychiatry and Behavioral Neuroscience,
University of Chicago, Chicago, USA
40 Department of Biostatistics and Bioinformatics, Duke
University, Durham, NC, USA
41 National Institute for Health and Welfare (THL), Helsinki,
Finland
42 Department of General Practice and Primary Health Care,
University of Helsinki, Helsinki, Finland
43 Unit of General Practice and Primary Health Care, University
of Helsinki, Helsinki, Finland
44 Vasa Central Hospital, Vaasa, Finland
45 Interfaculty Institute for Genetics and Functional Genomics,
University of Greifswald, Greifswald, Germany
46 Translational Research Institute, University of Queensland
Diamantina Institute, Brisbane, Australia
47 Department of Molecular and Translational Medicine,
University of Brescia, Brescia, Italy
48 Department of Biotechnology, University of Tartu, Tartu,
Estonia
49 Department of Psychiatry, EMGO? Institute, Neuroscience
Campus Amsterdam, VU University Medical Center,
Amsterdam, The Netherlands
50 Institute of Clinical Chemistry and Laboratory Medicine,
University Medicine Greifswald, Greifswald, Germany
51 Wellcome Trust Sanger Institute, Wellcome Trust Genome
Campus, Hinxton, Cambridge, UK
52 Institute for Molecular Medicine Finland (FIMM), University
of Helsinki, Helsinki, Finland
53 Department of Public Health, Faculty of Medicine,
University of Split, Split, Croatia
54 Department of Clinical Physiology and Nuclear Medicine,
Turku University Hospital, Turku, Finland
55 Research Centre of Applied and Preventive Cardiovascular
Medicine, University of Turku, Turku, Finland
56 Department of Psychological & Brain Sciences, Indiana
University, Bloomington, IN, USA
57 Department of Psychological Sciences and Missouri
Alcoholism Research Center, University of Missouri,
Columbia, MO, USA
58 Alzheimer Scotland Dementia Research Centre, University of
Edinburgh, Edinburgh, UK
59 School of Oral and Dental Sciences, University of Bristol,
Bristol, UK
60 School of Experimental Psychology, University of Bristol,
Bristol, UK
61 College of Medicine, Florida State University, Tallahassee,
FL, USA
172 Behav Genet (2016) 46:170–182
123
individuals who had completed at least two different per-
sonality questionnaires. Next, based on calibrated item
parameters, personality scores were estimated based on all
available data for each individual, irrespective of what
personality questionnaire was used. The harmonized
extraversion phenotype was heritable. A broad-sense heri-
tability of 49 % was estimated, based on a meta-analysis in
six twin cohorts that are included in the GPC (29,501 twin
pairs), of which 24 % was due to additive genetic variance
and 25 % due to non-additive genetic variance. The broad-
sense heritability estimate is similar to heritability esti-
mates obtained for extraversion as assessed with single
measurement instruments (Bouchard and Loehlin 2001;
Distel et al. 2009b; Finkel and McGue 1997; Keller et al.
2005; Rettew et al. 2008; Yamagata et al. 2006). Some
evidence for qualitative sex differences in the genetic
influences on extraversion was suggested by a genetic
correlation in opposite-sex twin pairs of 0.38 (van den Berg
et al. 2014). Extraversion becomes more genetically stable
during adolescence until it is almost perfectly genetically
stable in adulthood (Briley and Tucker-Drob 2014; Kandler
2012), that is, the same genes are responsible for
extraversion measured at different ages.
A handful of genome-wide association (GWA) studies for
extraversion have been published, aimed at detecting
specific single nucleotide polymorphisms (SNPs) that
explain part of the heritability. The first GWA study for
personality, which focused on the five NEO personality
traits, was conducted in 3972 adults (Terracciano et al.
2010). No genome-wide significant SNP associations were
found for extraversion, although some interesting associa-
tions with P-values \10-5 were seen with SNPs in two
cadherin genes and the brain-derived neurotrophic factor
(BDNF) gene. A subsequent meta-analysis of GWA results
for the NEO personality traits, conducted in 17,375 subjects,
also did not yield any genome-wide significant associations
for extraversion (De Moor et al. 2012). Two other GWA
studies reported a similar lack of genome-wide significance
for Cloninger’s temperament scales (Service et al. 2012;
Verweij et al. 2010). Interestingly, a study that performed a
genetic complex trait analysis (GCTA; Yang et al. 2010) for
neuroticism and extraversion in around 12,000 unrelated
individuals reported that 12 % (SE = 3 %) of the variance
in extraversion was explained by common SNPs of additive
effect (Vinkhuyzen et al. 2012). Taken together, the results
from twin and genome-wide studies suggest that common
SNPs of additive effect are important, that genetic non-ad-
ditivity may play a role, and that large sample sizes are likely
to be required to identify specific variants.
In this paper, we report the results of the largest meta-
analysis of GWA results for extraversion so far, carried out
in 29 cohorts that participate in the GPC. A total of 63,030
subjects with harmonized extraversion and genome-wide
genotype data were included in the meta-analysis. A 30th
cohort was used for replication. In this consortium we
reported earlier on a genome-wide significant hit for neu-
roticism (De Moor et al. 2015), indicating that we may
begin to analyze data from sufficiently large samples, to
obtain the first significant findings from GWA studies for
personality. In addition to meta-analysis of GWA results,
we computed weighted polygenic scores in an independent
cohort and associated them with extraversion, and esti-
mated variance explained by SNPs in two large cohorts.
Materials and methods
Cohorts
The full meta-analysis was performed on 63,030 subjects
from 29 discovery cohorts. All samples were of European
origin. Twenty-one cohorts were from Europe, six from the
United States and two from Australia. Sample sizes of the
individual cohorts ranged from 177 to 7210 subjects. Please
note that some cohorts were also part of previously published
GWA studies on extraversion. The Generation Scotland:
Scottish Family Health Study (GS:SFHS) cohort was
included as a replication sample (9,783 subjects). A brief
overview of all cohorts is provided in Table 1. A description
of each individual cohort is found in the Supplementary
materials and methods (see also De Moor et al. 2015).
Phenotyping
A harmonized latent extraversion score was estimated for
all participants in all 29 cohorts that were included in the
GWA meta-analysis. This score was based on all available
extraversion item data for each individual (for a detailed
62 Department for Health Evidence, Radboud University
Medical Center, Nijmegen, The Netherlands
63 Department of Public Health and Primary Care, Trinity
College Dublin, Dublin, Ireland
64 Scottish Family Health Study, A Collaboration Between the
University Medical Schools and NHS,
Aberdeen, Dundee, Edinburgh and Glasgow, UK
65 Medical Genetics Section, Centre for Genomics and
Experimental Medicine, Institute of Genetics and Molecular
Medicine, Western General Hospital, The University of
Edinburgh, Edinburgh, UK
66 Department of Psychiatry and Psychotherapy, HELIOS
Hospital Stralsund, Stralsund, Germany
67 Laboratory of Genetics, National Institute on Aging, National
Institutes of Health, Baltimore, MD, USA
68 Institute of Public Health, University of Southern Denmark,
Odense, Denmark
Behav Genet (2016) 46:170–182 173
123
description see van den Berg et al. 2014). Extraversion
item data came from the extraversion scales of the NEO
Personality Inventory, the NEO Five Factor Inventory, the
50-item Big-Five version of the International Personality
Item Pool inventory, the Eysenck Personality Question-
naire and the Eysenck Personality Inventory, from the
Reward Dependence scale of the Cloninger’s Tridimen-
sional Personality Questionnaire, and from the Positive
Emotionality scale of the Multidimensional Personality
Questionnaire (see van den Berg et al. 2014 and Supple-
mentary materials and methods). In the GS:SFHS cohort
that was included for replication of top signals, extraver-
sion was based on the summed score of the extraversion
scale of the EPQ Revised Short Form.
Genotyping and imputation
Genotyping in all cohorts was carried out on Illumina or
Affymetrix platforms, after which quality control (QC) was
performed, followed by imputation of genotypes. QC of
genotype data was performed in each cohort separately,
with comparable but cohort specific criteria. Standard QC
checks included tests of European ancestry, sex inconsis-
tencies, Mendelian errors, and high genome-wide
homozygosity. Checks for relatedness were conducted in
those cohorts that aimed to include unrelated individuals
only. Other checks of genotype data were based on minor
allele frequencies (MAF), SNP call rate (% of subjects with
missing genotypes per SNP), sample call rate (% of miss-
ing SNPs per subject) and Hardy–Weinberg Equilibrium
(HWE). Genotype data were imputed using the 1000Gen-
omes phase 1 version 3 (build37, hg19) reference panel
with standard software packages such as IMPUTE, MACH,
or Minimac, see Supplementary Table 1.
Statistical analyses
GWA analysis per cohort
GWA analyses were conducted independently in each
cohort. Since the cohorts used different research designs
(case–control, population twin studies, extended pedigrees,
etc.), GWA methods were optimized for each cohort.
Extraversion scores were regressed on each SNP under an
additive model, with sex and age included as covariates.
Covariates such as ancestry Principal Components (PCs)
were added if deemed necessary for a particular cohort. In
all analyses, the uncertainty of the imputed genotypes was
taken into account, either using dosage scores or mixtures
of distributions. In those cohorts that included related
individuals, the dependency among participants was
accounted for using cohort-specific methods. Standard
software packages for GWA analyses were used (see
Supplementary Table 1).
Meta-analysis of GWA results across cohorts
A meta-analysis of the GWA results was conducted
with the weighted inverse variance method in METAL
(http://www.sph.umich.edu/csg/abecasis/metal/index.html).
Excluded from meta-analysis were poorly imputed SNPs
(r2\ 0.30 or proper_info\ 0.40) and SNPs with low
Table 1 Overview of 29 discovery cohorts and 1 replication cohort
of the Genetics of Personality Consortium
Cohort # Subjectsa # SNPsb
1 ALSPAC 4705 6,454,153
2 BLSA 820 4,989,411
3 BRESCIA 177 3,549,919
4 CHICAGO 311 3,755,416
5 CILENTO 627 1,123,089
6 COGA 647 5,127,101
7 COGEND 1279 5,932,838
8 EGCUT 1184 5,574,695
9 ERF 2300 5,142,865
10 FTC EPI 567 4,870,096
11 FTC NEO 813 5,092,018
12 HBCS 1456 5,612,790
13 CROATIA-Korcula 808 5,094,034
14 LBC1921 437 4,363,611
15 LBC1936 952 5,168,754
16 MCTFR 7099 6,569,999
17 MGS 2101 5,900,898
18 NBS 1832 5,603,447
19 NESDA 2227 4,707,569
20 NTR 6416 5,339,798
21 ORCADES 1650 4,265,590
22 PAGES 476 4,547,293
23 QIMR adolescents 2842 5,957,064
24 QIMR adults 7210 6,343,920
25 SardiNIA 4332 6,291,135
26 SHIP 2213 5,913,428
27 STR 4903 6,519,094
28 CROATIA-Vis 909 5,327,671
29 YFS 1737 5,914,679
Total 63,030 7,460,147
30 GS:SFHS 9783 74
NA Not Applicable for replication cohort because only top hits were
sought to replicatea Number of subjects with valid latent score for Extraversion and
SNP data (after imputation and cleaning)b Number of SNPs (after imputation and cleaning) with valid asso-
ciation results that entered the meta-analysis
174 Behav Genet (2016) 46:170–182
123
MAF (MAF\H(5/N), which corresponds to less than 5
estimated individuals in the least frequent genotype group,
under the assumption of HWE). This resulted in a total
number of 7,460,147 unique SNPs in the final meta-anal-
ysis (with 1.1–6.6 M SNPs across cohorts). For 2182 SNPs,
SNP locations could not be matched with rs names. For an
additional 516,362 SNPS, results were based on one cohort
only and therefore left out of the analysis, so that the results
are based on 6,941,603 SNPs. Genomic control inflation
factors (lambda), Manhattan plots and quantile–quantile
plots per cohort are provided in Supplementary Table 2
and Supplementary Figs. 1, 2. A P value of 5 9 10-8 was
used as the threshold for genome-wide significance.
The meta-analysis results (P-values per SNP) were used
as the input to compute P-values at the gene level. We
performed these analyses in KGG (Li et al. 2012). A P-
value of 2.87 9 10-6 was used as the threshold for gen-
ome-wide significance in these gene-wide analyses, based
on controlling for the false-discovery rate (Benjamini and
Hochberg 1995).
All GWAS SNP top hits with a P-value smaller than
1 9 10-5 were selected for replication in the GS:SFHS
cohort.
Polygenic risk score analysis
Additional analyses were conducted to test whether
extraversion could be predicted in an independent target
cohort based on the GWA meta-analysis results. The target
cohort was the Netherlands Twin Register (NTR) cohort
(8648 subjects). Polygenic risk scores for this cohort were
estimated using LDpred (Vilhjalmsson et al. 2015) that
takes into account linkage disequilibrium among the SNPs.
The estimation was based on a GWA meta-analysis in
which the NTR and NESDA cohorts were excluded (fur-
ther referred to as the discovery set). With the LD-cor-
rected polygenic risk scores, generalized estimating
equation (GEE) modeling was applied to test whether the
polygenic risk scores predicted extraversion in the target
cohort. The covariates age, sex and ten PCs were included
as fixed effects in the model. The model also included a
random intercept with family number as the cluster vari-
able, to account for dependency among family members.
Outliers on the PCs, including ethnic outliers, were
excluded from the analysis.
Variance explained by SNPs
In the NTR cohort and the QIMR Berghofer Medical
Research Institute (QIMR) adult cohort (see also Supple-
mentary materials and methods), GCTA software (Visscher
et al. 2010; Yang et al. 2010) was used to estimate the
proportion of variance in extraversion that can be explained
by common SNPs of additive effect. In the NTR, this
analysis was carried out in a set of 3597 unrelated indi-
viduals and in the QIMR adult cohort this was done in 3369
unrelated individuals (in each cohort one member per
family was selected with harmonized extraversion and
genome-wide SNP data). GCTA analysis was based on best
guess genotypes obtained in PLINK using a threshold of a
maximum genotype probability [0.70, and additionally
filtering on r-squared[0.80. Next, in estimating the GRM
matrix in the GCTA software, SNPs with MAF\0.05 were
excluded. The additive genetic relationship matrices
(GRM) estimated based on SNPs for all individuals formed
the basis to estimate the proportion of phenotypic variance
explained by SNPs in the NTR and QIMR cohorts. In other
words, it was determined to what extent phenotypic simi-
larity between individuals corresponds to genetic similarity
(at the SNP level). For both NTR and QIMR, sex, age and a
set of population-specific PCs were included as covariates.
Results
Meta-analysis of GWA results
Meta-analysis of GWA results across the 29 discovery
cohorts did not yield genome-wide significant SNPs asso-
ciated with extraversion. The lowest P-value observed was
2.9 9 10-7 for a SNP located on chromosome 2. There
were 74 SNPs with P-values \1 9 10-5. The Manhattan
and quantile–quantile plots are provided in Figs. 1 and 2. A
list with the top five SNPs is given in Table 2. A list with
all SNPs that reached the level of suggestive genome-wide
significance (P\ 1 9 10-5) is found in Supplementary
Table 3. The results of all SNPs can be downloaded from
www.tweelingenregister.org/GPC. A gene-based test
showed one significant hit for LOC101928162, a long non-
coding RNA site, P = 2.87 9 10-6. A list with the top five
genes from the gene-based analysis is provided in Table 3.
Supplementary Table 4 provides the top 30 genes. Among
the top 30 genes was Brain-Derived Neurotrophic Factor
(BDNF, P = 0.0003), a gene also implicated, though not
genome-wide significant, in Terracciano et al. (2010), as
was the BDNF anti-sense RNA gene (P = 0.0001).
Results of the follow-up analysis of the top five SNPs in
the GS:SFHS cohort can be found in Table 2. Of the top
five SNPs, none showed a significant effect. For an over-
view of the replication results of all top SNPs with P-value
\1 9 10-5 see Supplementary Table 3. Of the 74 SNPs
tested in the replication cohort, three SNPs showed nomi-
nal evidence of association (P\ 0.05), which is less than
the number expected based on chance alone
(0.05 9 74 = 3.7).
Behav Genet (2016) 46:170–182 175
123
Polygenic risk score analysis
There were 8201 persons individuals with polygenic scores
for prediction of extraversion. The LDpred-based genetic
risk scores significantly predicted extraversion in the target
cohort, B = 0.059, X2(1) = 27.30, P\ 0.001.
Variance explained by SNPs
In the NTR cohort, an estimated 5.0 % (SE = 7.2) of the
variance in extraversion was explained by all SNPs, but
this estimate was not significantly different from zero
(P = 0.24). In the QIMR cohort, 0.0001 % (SE = 15) of
the variance was explained by SNPs (P = 0.46).
Discussion
This study assessed the influence of common genetic
variants on extraversion in 63,030 individuals from 29
cohorts in the GPC. First, a meta-analysis of GWA anal-
yses across 29 discovery cohorts showed no genome-wide
significant SNPs. Top SNPs detected in the meta-analysis
of GWA results in the discovery phase were not replicated
in the GS:SFHS cohort. The SNPs with lowest P-values
have no previously reported relationship with personality,
psychopathology or brain functioning. Polygenic risk
scores based on the meta-analysis results predicted
extraversion in an independent data set. SNP-based
Fig. 1 Manhattan plot for meta-analysis results of 29 discovery cohorts for extraversion in the Genetics of Personality Consortium
Fig. 2 Quantile-Quantile plots for meta-analysis results of 29
discovery cohorts for extraversion in the Genetics of Personality
Consortium
Table 2 Top SNPs from the meta-analysis of GWA results in 29 discovery cohorts for extraversion, and their replication in the GS:SFHS
cohort, in the Genetics of Personality Consortium
SNP Chr_BP Alleles Closest gene Discovery results Replication results
Effect SE P-value Effect SE P-value
rs2024488 2_217662968 A/G LOC101928250 -0.0303 0.0059 2.939 x 10-7 0.0285 0.0164 0.08244
rs2712162 2_217661788 T/C LOC101928250 -0.0300 0.0059 3.872 x 10-7 0.0278 0.0164 0.08947
rs797182 12_10900487 A/G \NA[ -0.0277 0.0056 6.673 x 10-7 -0.0135 0.0153 0.37721
rs8010306 14_37150160 A/G SLC25A21 0.0629 0.0128 8.730 x 10-7 0.0180 0.0314 0.56650
rs117292860 19_2227621 A/C DOT1L 0.0553 0.0113 9.191 x 10-7 -0.0350 0.0239 0.14368
176 Behav Genet (2016) 46:170–182
123
heritabilities for extraversion were not significantly dif-
ferent from zero in two large cohorts of the GPC.
Although there were no genome-wide significant results
for individual SNPs, in the gene-based analysis, there was
a significant hit for one locus, LOC101928162. This is
long noncoding RNA site whose function remains elusive.
Interestingly, among the top 30 genes were genes previ-
ously implicated in extraversion or in psychiatric disorders
associated with extraversion. The low P-value for
CRTAC1 (P = 2.97 x 10-5), harks back to an interesting
extraversion SNP (rs7088779) in a previous GWAS on
personality (Amin et al. 2013) that is located
between CRTAC1 and C10orf28. RELN (P = 5.69 x 10-5)
has been reported to increase the risk for schizophrenia and
bipolar disorder (Kuang et al. 2011; Ovadia and Shifman
2011), while ADAM12 (7.65 x 10-5) was previouslyfound
to be involved in schizophrenia (Farkas et al. 2010),
and bipolar disorder treatment (Nadri et al.
2007). The BDNF gene was also implicated in a previous
extraversion GWAS (Terracciano et al. 2010), though not
genome-wide significant. Liu et al. (2005) reported a trend
towards association of BDNF variants with substance
abuse, Jiao et al. (2011) reported an association with obe-
sity, and Lang et al. (2007) and Beuten et al. (2005) re-
ported associations with smoking behavior. As
extraversion is known to be associated with lifestyle,
obesity and substance abuse, we deem BDNF to be an
interesting candidate gene for extraversion in future stud-
ies, along with CRTAC, ADAM12 and RELN.
With the current meta-analysis we more than tripled the
sample size as compared to the largest previously published
meta-analysis for extraversion (De Moor et al. 2012). In
contrast to neuroticism, no genome-wide significant SNPs
were found. Some have argued (Turkheimer et al. 2014) that
the heritability of personality traits represents nonspecific
genetic background, which is composed of so many genetic
variants with extremely small effect sizes that individually
these have no causal biological interpretation. It may be that
extraversion differs in this respect from neuroticism. One
other difference was indicated from the analyses of the IRT-
based extraversion and neuroticism scores: whereas for
neuroticism no evidence for genotype x sex interaction was
seen (van den Berg et al. 2014), for extraversion there was
significant evidence for sex limitation. It also is interesting to
note that despite the fact that for extraversion no genome-
wide significant findings emerged for single SNPs, we were
able to predict extraversion in an independent dataset, based
on the polygenic risk cohorts from the discovery set. This
indicates that some true signal is entailed in the meta-anal-
ysis results.
The results of the polygenic risk score analysis are in
contrast with the results from the GCTA analysis, in which
no significant proportion of variance explained by SNPs
was detected in two large cohorts of the GPC. Our study on
neuroticism reported a SNP-based heritability of 15 % (De
Moor et al. 2015). The current extraversion GCTA findings
are also somewhat at odds with two previous GCTA studies
for personality traits. One study focused on neuroticism
and extraversion as measured with different instruments in
four cohorts, and found on average 12 % explained vari-
ance for extraversion, although across cohorts these esti-
mates varied widely (0–27 %) (Vinkhuyzen et al. 2012).
Estimates for neuroticism also varied, but were generally
lower than for extraversion in this study, with an average of
6 % explained variance. In another study, between 4.2 and
9.9 % of explained variances were found for the four
Cloninger temperaments in a combined sample of four
cohorts (Verweij et al. 2012). The proportions of variances
for Harm Avoidance, Novelty Seeking and Persistence
were significant at P\ 0.05, whereas interestingly the
proportion of variance for Reward Dependence was not. It
should be noted that both these studies included the QIMR
cohort in their analyses, so there is some overlap in sub-
jects across studies. The difference is that in the earlier
studies extraversion and reward dependence were based on
single personality inventories, while in our study
extraversion scores harmonized among different personal-
ity inventories were analyzed. What our results and the
results in the previous studies have in common though, is
that the estimates are considerably smaller than the heri-
tability estimates based on twin studies. Given that about
half of the heritability of extraversion consists of non-ad-
ditive genetic variance (van den Berg et al. 2014), it is not
unlikely that this discrepancy is caused by the influence of
Table 3 Top genes from the meta-analysis of GWA results in 29 discovery cohorts for Extraversion in the Genetics of Personality Consortium
Gene Full gene name Pathways P-value
LOC101928162 [Long non-coding RNA] Unknown 0.00000287
LOC729506 [Long non-coding RNA] Unknown 0.00000893
PLEKHJ1 Pleckstrin Homology Domain Containing, Family J
Member 1
Phospholipid binding, circadian clock
functioning
0.0000132
POU2F3 POU Class 2 Homeobox 3 Influenza A 0.0000179
CRTAC1 Cartilage Acidic Protein 1 Unknown 0.0000297
Behav Genet (2016) 46:170–182 177
123
common variants that interact within loci (dominance) or
across loci (epistasis). In addition, the influence of rare
variants may be implicated. The relatively limited influ-
ence of common additive genetic variation, as well as a
previously reported finding that higher levels of inbreeding
are associated with less socially desirable personality trait
levels, has led to the idea that the genetic variation in
personality traits may have been maintained by mutation–
selection balance (Verweij et al. 2012), and our results are
consistent with this idea.
This study comes with some limitations. Genotyping,
QC, and imputation were carried out separately in each
cohort. Any difference in procedures may have caused
some loss of statistical power to detect SNPs in the meta-
analysis. Similarly, extraversion item data were harmo-
nized as much as possible (van den Berg et al. 2014), but
the Reward Dependence item data from the TCI were least
successfully linked to the extraversion data from the other
inventories. This may also have caused some loss in power.
Importantly however, it should be noted that by combining
genotype and phenotype data across cohorts as performed
in this study, a substantial increase in sample size was
obtained. It is nontrivial that the gain in power associated
with this increase in sample size largely outweighs any
potential loss in power due to any remaining genotyping or
phenotyping differences across cohorts.
In conclusion, extraversion is a heritable, highly poly-
genic personality trait with a genetic background that may
be qualitatively different from that of other complex
behavioral traits. Future studies are required to increase our
knowledge of which types of genetic variants, by which
modes of gene action, constitute the heritable nature of
extraversion. Ultimately, this knowledge can be used to
increase our understanding of how extraversion is related
to various important psychosocial and health outcomes.
Acknowledgments We would like to thank all participating sub-
jects. Analyses were carried out on the Genetic Cluster Computer
(http://www.geneticcluster.org), which is financially supported by the
Netherlands Organization for Scientific Research (NWO 480-05-003).
ALSPAC We are extremely grateful to all the families who took
part in this study, the midwives for their help in recruiting them and
the whole ALSPAC team, which includes interviewers, computer and
laboratory technicians, clerical workers, research scientists, volun-
teers, managers, receptionists and nurses. The UK Medical Research
Council (Grant 74882), the Wellcome Trust (Grant 076467) and the
University of Bristol provide core support for ALSPAC. We thank
23andMe for funding the genotyping of the ALSPAC children’s
sample. This publication is the work of the authors, and they will
serve as guarantors for the contents of this paper.
BLSA We acknowledge support from the Intramural Research
Program of the NIH, National Institute on Aging. We thank Robert
McCrae.
BRESCIA We acknowledge support from the Italian Ministry of
Health (RC and RF2007 Conv. 42) and Regione Lombardia (ID:
17387 SAL-13). We thank Ilaria Gandin for imputation analysis
support.
CHICAGO This work was supported by NIH Grants, DA007255
(ABH), HG006265 (to BEE), DA02812 (to HdW), and DA021336
and DA024845 (to AAP). BEE was also funded through the Bioin-
formatics Research Development Fund, supported by Kathryn and
George Gould. We wish to thank Andrew D. Skol for providing
advice about genotype calling.
CILENTO We acknowledge Dr Maria Enza Amendola for the test
administration and thank the personnel working in the organization of
the study in the villages. MC received funding support from the
Italian Ministry of Universities (FIRB - RBNE08NKH7, INTERO-
MICS Flaghip Project), the Assessorato Ricerca Regione Campania,
the Fondazione con il SUD (2011-PDR-13), and the Fondazione
Banco di Napoli.
SAGE – COGA/CONGEND Funding support for the Study of
Addiction: Genetics and Environment (SAGE) was provided through
the NIH Genes, Environment and Health Initiative [GEI] (U01
HG004422). SAGE is one of the genome-wide association studies
funded as part of the Gene Environment Association Studies (GEN-
EVA) under GEI. Assistance with phenotype harmonization and
genotype cleaning, as well as with general study coordination, was
provided by the GENEVA Coordinating Center (U01 HG004446).
Assistance with data cleaning was provided by the National Center
for Biotechnology Information. Support for collection of datasets and
samples was provided by the Collaborative Study on the Genetics of
Alcoholism (COGA; U10 AA008401) and the Collaborative Genetic
Study of Nicotine Dependence (COGEND; P01 CA089392). Funding
support for genotyping, which was performed at the Johns Hopkins
University Center for Inherited Disease Research, was provided by
the NIH GEI (U01HG004438), the National Institute on Alcohol
Abuse and Alcoholism, the National Institute on Drug Abuse, and the
NIH contract ‘‘High throughput genotyping for studying the genetic
contributions to human disease’’(HHSN268200782096C). The Col-
laborative Study on the Genetics of Alcoholism (COGA), Principal
Investigators B. Porjesz, V. Hesselbrock, H. Edenberg, L. Bierut,
includes ten different centers: University of Connecticut (V. Hessel-
brock); Indiana University (H.J. Edenberg, J. Nurnberger Jr., T.
Foroud); University of Iowa (S. Kuperman, J. Kramer); SUNY
Downstate (B. Porjesz); Washington University in St. Louis (L.
Bierut, A. Goate, J. Rice, K. Bucholz); University of California at San
Diego (M. Schuckit); Rutgers University (J. Tischfield); Texas
Biomedical Research Institute (L. Almasy), Howard University (R.
Taylor) and Virginia Commonwealth University (D. Dick). Other
COGA collaborators include: L. Bauer (University of Connecticut);
D. Koller, S. O’Connor, L. Wetherill, X. Xuei (Indiana University);
Grace Chan (University of Iowa); S. Kang, N. Manz, M. Rangaswamy
(SUNY Downstate); J. Rohrbaugh, J-C Wang (Washington University
in St. Louis); A. Brooks (Rutgers University); and F. Aliev (Virginia
Commonwealth University). A. Parsian and M. Reilly are the NIAAA
Staff Collaborators. This national collaborative study is supported by
NIH Grant U10AA008401 from the National Institute on Alcohol
Abuse and Alcoholism (NIAAA) and the National Institute on Drug
Abuse (NIDA). The Collaborative Genetic Study of Nicotine
Dependence (COGEND) project is a collaborative research group and
part of the NIDA Genetics Consortium. Subject collection was sup-
ported by NIH Grant P01 CA089392 (L.J. Bierut) from the National
Cancer Institute. Phenotypic and genotypic data are stored in the
NIDA Center for Genetic Studies (NCGS) at http://zork.wustl.edu/
under NIDA Contract HHSN271200477451C (J. Tischfield and J.
Rice). Jaime Derringer was supported by NIH T32 MH016880.
EGCUT AM and TE received support from FP7 Grants (201413
ENGAGE, 212111 BBMRI, ECOGENE (No. 205419, EBC)) and
OpenGENE. AM and TE also received targeted financing from
Estonian Government SF0180142s08 and by EU via the European
Regional Development Fund, in the frame of Centre of Excellence in
Genomics. The genotyping of the Estonian Genome Project samples
were performed in Estonian Biocentre Genotyping Core Facility, AM
178 Behav Genet (2016) 46:170–182
123
and TE thank Mari Nelis and Viljo Soo for their contributions. AR
and JA were supported by a grant from the Estonian Ministry of
Science and Education (SF0180029s08).
ERF The ERF study as a part of EUROSPAN (European Special
Populations Research Network) was supported by European Com-
mission FP6 STRP Grant Number 018947 (LSHG-CT-2006-01947)
and also received funding from the European Community’s Seventh
Framework Programme (FP7/2007-2013)/Grant agreement
HEALTH-F4-2007-201413 by the European Commission under the
programme ‘‘Quality of Life and Management of the Living
Resources’’ of 5th Framework Programme (no. QLG2-CT-2002-
01254). The ERF study was further supported by ENGAGE consor-
tium and CMSB. High-throughput analysis of the ERF data was
supported by joint grant from Netherlands Organisation for Scientific
Research and the Russian Foundation for Basic Research (NWO-
RFBR 047.017.043). ERF was further supported by the ZonMw Grant
(Project 91111025). We are grateful to all study participants and their
relatives, general practitioners and neurologists for their contributions
and to P. Veraart for her help in genealogy, J. Vergeer for the
supervision of the laboratory work and P. Snijders for his help in data
collection.
Finnish Twin Cohort (FTC) We acknowledge support from the
Academy of Finland Center of Excellence in Complex Disease
Genetics (Grant Numbers: 213506, 129680), the Academy of Finland
(Grants 100499, 205585, 118555 and 141054 to JK, Grant 257075 to
EV), Global Research Awards for Nicotine Dependence (GRAND),
ENGAGE (European Network for Genetic and Genomic Epidemiol-
ogy, FP7-HEALTH-F4-2007, Grant Agreement Number 201413),
DA12854 to P A F Madden, and AA-12502, AA-00145, and AA-
09203 to RJRose, AA15416 and K02AA018755 to DM Dick.
HBCS We thank all study participants as well as everybody
involved in the Helsinki Birth Cohort Study. Helsinki Birth Cohort
Study has been supported by grants from the Academy of Finland, the
Finnish Diabetes Research Society, Folkhalsan Research Foundation,
Novo Nordisk Foundation, Finska Lakaresallskapet, Signe and Ane
Gyllenberg Foundation, University of Helsinki, Ministry of Educa-
tion, Ahokas Foundation, Emil Aaltonen Foundation.
CROATIA-Korcula The CROATIA-Korcula study was funded by
grants from the Medical Research Council (UK), European Com-
mission Framework 6 project EUROSPAN (Contract No. LSHG-CT-
2006-018947) and Republic of Croatia Ministry of Science, Educa-
tion and Sports research Grants to I.R. (108-1080315-0302). We
would like to acknowledge the invaluable contributions of the
recruitment team in Korcula, the administrative teams in Croatia and
Edinburgh and the people of Korcula. The SNP genotyping for the
CROATIA-Korcula cohort was performed in Helmholtz Zentrum
Munchen, Neuherberg, Germany.
LBC1921 & LBC1936 For the Lothian Birth Cohorts, we thank
Paul Redmond for database management; Alan Gow, Michelle Tay-
lor, Janie Corley, Caroline Brett and Caroline Cameron for data
collection and data entry; nurses and staff at the Wellcome Trust
Clinical Research Facility, where blood extraction and genotyping
was performed; staff at the Lothian Health Board, and the staff at the
SCRE Centre, University of Glasgow. The research was supported by
a program grant from Research Into Ageing. The research continues
with program grants from Age UK (The Disconnected Mind). The
work was undertaken by The University of Edinburgh Centre for
Cognitive Ageing and Cognitive Epidemiology, part of the cross
council Lifelong Health and Wellbeing Initiative (MR/K026992/1).
Funding from the Biotechnology and Biological Sciences Research
Council (BBSRC) and Medical Research Council (MRC) is gratefully
acknowledged. IJD, DJP and colleagues receive support from Well-
come Trust Strategic Award 104036/Z/14/Z.
MCTFR We would like to thank Rob Kirkpatrick for his help
running analyses.
Research reported in this publication was supported by the National
Institutes of Health under award numbers R37DA005147,
R01AA009367, R01AA011886, R01DA013240, R01MH066140, and
U01DA024417.
MGS Samples were collected under the following grants: NIMH
Schizophrenia Genetics Initiative U01s: MH46276, MH46289, and
MH46318; and Molecular Genetics of Schizophrenia Part 1 (MGS1)
and Part 2 (MGS2) R01s: MH67257, MH59588, MH59571,
MH59565, MH59587, MH60870, MH60879, MH59566, MH59586,
and MH61675. Genotyping and analyses were funded under the MGS
U01s: MH79469 and MH79470.
NBS Principal investigators of the Nijmegen Biomedical Study are
L.A.L.M. Kiemeney, M. den Heijer, A.L.M. Verbeek, D.W. Swinkels
and B. Franke.
NESDA The Netherlands Study of Depression and Anxiety
(NESDA) were funded by the Netherlands Organization for Scientific
Research (Geestkracht program Grant 10-000-1002); the Center for
Medical Systems Biology (CMSB, NWO Genomics), Biobanking and
Biomolecular Resources Research Infrastructure (BBMRI-NL), VU
University’s EMGO Institute for Health and Care Research and
Neuroscience Campus Amsterdam. Genotyping was funded by the US
National Institute of Mental Health (RC2MH089951) as part of the
American Recovery and Reinvestment Act of 2009. BP is financially
supported by NWO-VIDI Grant No. 91811602.
NTR We acknowledge financial support from the Netherlands
Organization for Scientific Research (NWO): Grants 575-25-006,
480-04-004, 904-61-090; 904-61-193, 400-05-717 and Spinozapremie
SPI 56-464-14192 and the European Research Council (ERC-
230374). MHMdeM is supported by NWO VENI Grant No. 016-115-
035. Genotyping was funded by the Genetic Association Information
Network (GAIN) of the Foundation for the US National Institutes of
Health, and analysis was supported by grants from Genetic Associ-
ation Information Network and the NIMH (MH081802). Genotype
data were obtained from dbGaP (http://www.ncbi.nlm.nih.gov/dbgap,
accession number phs000020.v1.p1).
ORCADES was supported by the Chief Scientist Office of the
Scottish Government, the Royal Society, the MRC Human Genetics
Unit, Arthritis Research UK and the European Union framework
program 6 EUROSPAN project (contract no. LSHG-CT-2006-
018947). DNA extractions were performed at the Wellcome Trust
Clinical Research Facility in Edinburgh. We would like to
acknowledge the research nurses in Orkney, the administrative team
in Edinburgh and the people of Orkney.
PAGES none.
QIMR Berghofer adolescents/adults We thank Marlene Grace and
Ann Eldridge for sample collection; Megan Campbell, Lisa Bowdler,
Steven Crooks and staff of the Molecular Epidemiology Laboratory
for sample processing and preparation; Harry Beeby, David Smyth
and Daniel Park for IT support. We acknowledge support from the
Australian Research Council Grants A79600334, A79906588,
A79801419, DP0212016, DP0343921, DP0664638, and DP1093900
(to NGM and MJW), Beyond Blue and the Borderline Personality
Disorder Research Foundation (to NGM), NIH Grants DA12854 (to
PAFM), AA07728, AA07580, AA11998, AA13320, AA13321 (to
ACH) and MH66206 (to WSS); and grants from the Australian
National Health and Medical Research Council; MLP is supported by
DA019951. Genotyping was partly funded by the National Health and
Medical Research Council (Medical Bioinformatics Genomics Pro-
teomics Program, 389891) and the 5th Framework Programme (FP-5)
GenomEUtwin Project (QLG2-CT-2002-01254). Further genotyping
at the Center for Inherited Disease Research was supported by a grant
to the late Richard Todd, M.D., Ph.D., former Principal Investigator
of Grant AA13320. SEM and GWM are supported by the National
Health and Medical Research Council Fellowship Scheme. Further,
we gratefully acknowledge Dr Dale R Nyholt for his substantial
Behav Genet (2016) 46:170–182 179
123
involvement in the QC and preparation of the QIMR GWA data sets.
Dr Nyholt also contributed 8 % of the GWAS for the QIMR adult
cohort (NHMRC IDs 339462, 442981, 389938, 496739).
SardiNIA We acknowledge support from the Intramural Research
Program of the NIH, National Institute on Aging. Funding was pro-
vided by the National Institute on Aging, NIH Contract No. NO1-AG-
1-2109 to the SardiNIA (‘ProgeNIA’) team.
SHIP SHIP is part of the Community Medicine Research net of the
University of Greifswald, Germany, which is funded by the Federal
Ministry of Education and Research (Grants No. 01ZZ9603,
01ZZ0103, and 01ZZ0403), the Ministry of Cultural Affairs and the
Social Ministry of the Federal State of Mecklenburg-West Pomerania.
Genome-wide data have been supported by the Federal Ministry of
Education and Research (Grant No. 03ZIK012) and a joint grant from
Siemens Healthcare, Erlangen, Germany and the Federal State of
Mecklenburg-West Pomerania. The University of Greifswald is a
member of the ‘Center of Knowledge Interchange’ program of the
Siemens AG. This work was also funded by the German Research
Foundation (DFG: GR 1912/5-1).
STR The STR was supported by grants from the Ministry for
Higher Education, the Swedish Research Council (M-2005-1112 and
2009-2298), GenomEUtwin (EU/QLRT-2001-01254; QLG2-CT-
2002-01254), NIH Grant DK U01-066134, The Swedish Foundation
for Strategic Research (SSF; ICA08-0047), the Swedish Heart–Lung
Foundation, the Royal Swedish Academy of Science, and ENGAGE
(within the European Union Seventh Framework Programme,
HEALTH-F4-2007-201413).
CROATIA-Vis The CROATIA-Vis study was funded by grants
from the Medical Research Council (UK) and Republic of Croatia
Ministry of Science, Education and Sports research Grants to I.R.
(108-1080315-0302). We would like to acknowledge the staff of
several institutions in Croatia that supported the field work, including
but not limited to The University of Split and Zagreb Medical
Schools, the Institute for Anthropological Research in Zagreb and
Croatian Institute for Public Health. The SNP genotyping for the
CROATIA-Vis cohort was performed in the core genotyping labo-
ratory of the Wellcome Trust Clinical Research Facility at the Wes-
tern General Hospital, Edinburgh, Scotland.
YFS The Young Finns Study has been financially supported by the
Academy of Finland (Grants 126925, 121584, 124282, 129378
(Salve), 117787 (Gendi), 41071 (Skidi), and 265869 (Mind)), the
Social Insurance Institution of Finland, Kuopio, Tampere and Turku
University Hospital Medical Funds (Grant 9N035 for Dr. Lehtimaki),
Juho Vainio Foundation, Paavo Nurmi Foundation, Finnish Founda-
tion of Cardiovascular Research and Finnish Cultural Foundation,
Tampere Tuberculosis Foundation and Emil Aaltonen Foundation (for
Dr. Lehtimaki). The expert technical assistance in statistical analysis
by Irina Lisinen, Mika Helminen, and Ville Aalto is gratefully
acknowledged.
GS:SHFHS GS:SFHS is funded by the Scottish Executive Health
Department, Chief Scientist Office, Grant Number CZD/16/6. Exome
array genotyping for GS:SFHS was funded by the Medical Research
Council UK and performed at the Wellcome Trust Clinical Research
Facility Genetics Core at Western General Hospital, Edinburgh, UK.
We would like to acknowledge the invaluable contributions of the
families who took part in the GS:SFHS, the general practitioners and
Scottish School of Primary Care for their help in recruiting them, and
the whole GS:SFHS team, which includes academic researchers, IT
staff, laboratory technicians, statisticians and research managers.
Authors’ contributions Writing group: SMvdB, MHMdeM,
KJHV, RFK, ML, AAV, LKM, JD, TE, DIB. Analytic group:
MHMdeM, SMvdB, KJHV, ML, AAV, LKM, JDe, TE, NA, SG,
NKH, ABH, JH, BK, JL, ML, MM, TT, ATeu, AV, JW, IOF, NT,
DME, TL, IS, EP, GRA, JM, HM, AA, MN. Study design and project
management: LF, LPR, JGE, AAP, GWM, MJW, PAFM, DP, AMin,
AP, DR, MC, IG, CH, IR, AMet, JK, IJD, KR, JFW, LKJ, JMH, HJG,
BWJHP, CMvD, DME, NLP, PTC, ATer, MMG, NGM, DIB, RFK,
AAV, GDS, TL, OTR, PKEM, KH, JMS, DS, GRA, HC, WGI, JDi.
Sample and phenotype data collection: BWJHP, AMet, AR, JA,
PAFM, ACH, NGM, MJW, KA, MN, LJB, JGE, LF, PTC, IG, AMH,
ATer, GDS, MGK, HdW, AAP, AKH, WSS, RS, DR, Amin, MJ,
LPR, LKJ, OTR, PKEM, EV, KH, AM, FB, OP, LZ. Data prepara-
tion: SMvdB, MHMdeM, JW, KGO, JJH, SEM, NKH, YM, TE, AR,
GD, ML, RG, AA, JD, EW, GD, BEE, COS, GH, KJHV, SDG, DEA,
TBB, JPK, NJT, BP, BK, CM, MJ, AL, ARS, ATer, DCL, HT.
Conflict of Interest The authors declare that they have no conflict
of interest.
Human and Animal Rights and Informed Consent All proce-
dures performed in studies involving human participants were in
accordance with the ethical standards of the institutional and/or
national research committee and with the 1964 Helsinki declaration
and its later amendments or comparable ethical standards. Informed
consent was obtained from all individual participants included in the
study.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://crea
tivecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were
made.
References
Amin N, Hottenga JJ, Hansell NK, Janssens ACJW, de Moor MHM,
Madden PAF, Zorkoltseva IV, Penninx BW, Terracciano A,
Uda M, Tanaka T, Esko T, Realo A, Ferrucci L, Luciano M,
Davies G, Metspalu A, Abecasis GR, Deary IJ, Raikkonen K,
Bierut LJ, Costa PT, Saviouk V, Zhu G, Kirichenko AV, Isaacs
A, Aulchenko YS, Willemsen G, Heath AC, Pergadia ML,
Medland SE, Axenovich TI, de Geus E, Montgomery GW,
Wright MJ, Oostra BA, Martin NG, Boomsma DI, van Duijn
CM (2013) Refining genome-wide linkage intervals using a
meta-analysis of genome-wide association studies identifies loci
influencing personality dimensions. Eur J Hum Genet
21(8):876–882
Benjamini Y, Hochberg Y (1995) Controlling the false discovery
rate—a practical and powerful approach to multiple testing. J R
Stat Soc Series B-Methodol 57(1):289–300
Beuten J, Ma JZ, Payne TJ, Dupont RT, Quezada P, Huang WH,
Crews KA, Li MD (2005) Significant association of BDNF
haplotypes in European-American male smokers but not in
European-American female or African-American smokers. Am J
Med Genet B 139b(1):73–80
Bouchard TJ, Loehlin JC (2001) Genes, evolution, and personality.
Behav Genet 31(3):243–273
Briley DA, Tucker-Drob EM (2014) Genetic and environmental
continuity in personality development: a meta-analysis. Psychol
Bull 140(5):1303–1331
Church AT (1994) Relating the tellegen and 5-factor models of
personality structure. J Pers Soc Psychol 67(5):898–909
Cloninger CR (1987) A systematic method for clinical description
and classification of personality variants—a proposal. Arch Gen
Psychiatry 44(6):573–588
180 Behav Genet (2016) 46:170–182
123
Cloninger CR, Svrakic DM, Przybeck TR (1993) A psychobiological
model of temperament and character. Arch Gen Psychiatry
50(12):975–990
Costa PT, McCrae RR (1992) Professional manual: revised NEO
personality inventory (NEO-PI-R) and NEO five-factor-inven-
tory (NEO-FFI). Psychol Assess Resour, Odessa
De Fruyt F, Van De Wiele L, Van Heeringen C (2000) Cloninger’s
psychobiological model of temperament and character and the
five-factor model of personality. Pers Indiv Differ 29(3):441–452
De Moor MHM, Beem AL, Stubbe JH, Boomsma DI, de Geus EJC
(2006) Regular exercise, anxiety, depression and personality: a
population-based study. Prev Med 42(4):273–279
De Moor MHM, Vink JM, van Beek JHDA, Geels LM, Bartels M, de
Geus EJC, Willemsen AHM, Boomsma DI (2011) Heritability of
problem drinking and the genetic overlap with personality in a
general population sample. Front Behav Psychiatr Genet 2:76
De Moor MH, Costa PT, Terracciano A, Krueger RF, de Geus EJ,
Toshiko T, Penninx BW, Esko T, Madden PA, Derringer J, Amin
N, Willemsen G, Hottenga JJ, Distel MA, Uda M, Sanna S,
Spinhoven P, Hartman CA, Sullivan P, Realo A, Allik J, Heath
AC, Pergadia ML, Agrawal A, Lin P, Grucza R, Nutile T, Ciullo
M, Rujescu D, Giegling I, Konte B, Widen E, Cousminer DL,
Eriksson JG, Palotie A, Peltonen L, Luciano M, Tenesa A,
Davies G, Lopez LM, Hansell NK, Medland SE, Ferrucci L,
Schlessinger D, Montgomery GW, Wright MJ, Aulchenko YS,
Janssens AC, Oostra BA, Metspalu A, Abecasis GR, Deary IJ,
Raikkonen K, Bierut LJ, Martin NG, van Duijn CM, Boomsma
DI (2012) Meta-analysis of genome-wide association studies for
personality. Mol Psychiatry 17(3):337–349
De Moor MHM, van den Berg SM, Consortium GoP, Boomsma DI
(2015) Meta-analysis of genome-wide association studies for
neuroticism, and the polygenic association with major depressive
disorder. JAMA Psychiatry 72:642–650
Distel MA, De Moor MHM, Boomsma DI (2009a) Dutch translation
of the Personality Assessment Inventory-Borderline features
scale (PAI-BOR): norms, factor structure and reliability. Psychol
Gezondh 37(1):38–46
Distel MA, Trull TJ, Willemsen G, Vink JM, Derom CA, Lynskey
MT, Martin NG, Boomsma DI (2009b) The Five Factor Model
of personality and borderline personality disorder: a genetic
analysis of comorbidity. Biol Psychiatry 66:1131–1138
Eysenck HJ, Eysenck SBG (1964) Eysenck personality inventory.
Educational and Industrial Testing Service, San Diego
Eysenck HJ, Eysenck SBG (1975) Manual of the eysenck personality
questionnaire. Hodder & Stoughton, London
Eysenck SBG, Eysenck HJ, Barrett P (1985) A revised version of the
psychoticism scale. Pers Indiv Differ 6(1):21–29
Farkas N, Lendeckel U, Dobrowolny H, Funke S, Steiner J, Keilhoff
G, Schmitt A, Bogerts B, Bernstein HG (2010) Reduced density
of ADAM 12-immunoreactive oligodendrocytes in the anterior
cingulate white matter of patients with schizophrenia. World J
Biol Psychiatry 11(3):556–566
Finkel D, McGue M (1997) Sex differences and nonadditivity in
heritability of the multidimensional personality questionnaire
scales. J Pers Soc Psychol 72(4):929–938
Furnham A, Nuygards S, Chamorro-Premuzic T (2013) Personality,
assessment methods and academic performance. Instr Sci
41(5):975–987
Jiao H, Arner P, Hoffstedt J, Brodin D, Dubern B, Czernichow S,
van’t Hooft F, Axelsson T, Pedersen O, Hansen T, Sorensen
TIA, Hebebrand J, Kere J, Dahlman-Wright K, Hamsten A,
Clement K, Dahlman I (2011) Genome wide association study
identifies KCNMA1 contributing to human obesity. BMC Med
Genomics 4:51
Judge TA, Rodell JB, Klinger RL, Simon LS, Crawford ER (2013)
Hierarchical representations of the five-factor model of
personality in predicting job performance: integrating three
organizing frameworks with two theoretical perspectives. J Appl
Psychol 98(6):875–925
Kandler C (2012) Nature and nurture in personality development: the
case of neuroticism and extraversion. Curr Dir Psychol Sci
21(5):290–296
Keller MC, Coventry WL, Heath AC, Martin NG (2005) Widespread
evidence for non-additive genetic variation in Cloninger’s and
Eysenck’s personality dimensions using a twin plus sibling
design. Behav Genet 35(6):707–721
Kolen MJ, Brennan RL (2004) Test equating, scaling, and linking:
methods and practices. Springer, New York
Kuang WJ, Sun RF, Zhu YS, Li SB (2011) A new single-nucleotide
mutation (rs362719) of the reelin (RELN) gene associated with
schizophrenia in female Chinese Han. Genet Mol Res
10(3):1650–1658
Lang UE, Sander T, Lohoff FW, Hellweg R, Bajbouj M, Winterer G,
Gallinat J (2007) Association of the met66 allele of brain-
derived neurotrophic factor (BDNF) with smoking. Psychophar-
macology (Berl) 190(4):433–439
Li MX, Kwan JS, Sham PC (2012) HYST: a hybrid set-based test for
genome-wide association studies, with application to protein-
protein interaction-based association analysis. Am J Hum Genet
91(3):478–488
Liu Q-R, Walther D, Drgon T, Polesskaya O, Lesnick TG, Strain KJ,
de Andrade M, Bower JH, Maraganore DM, Uhl GR (2005)
Human brain derived neurotrophic factor (BDNF) genes, splic-
ing patterns, and assessments of associations with substance
abuse and Parkinson’s Disease. Am J Med Genet B Neuropsy-
chiatr Genet 134B(1):93–103
Middeldorp CM, de Moor MH, McGrath LM, Gordon SD, Black-
wood DH, Costa PT, Terracciano A, Krueger RF, de Geus EJ,
Nyholt, Tanaka T, Esko T, Madden PA, Derringer J, Amin N,
Willemsen G, Hottenga JJ, Distel MA, Uda M, Sanna S,
Spinhoven P, Hartman CA, Ripke S, Sullivan PF, Realo A, Allik
J, Heath AC, Pergadia ML, Agrawal A, Lin P, Grucza RA,
Widen E, Cousminer DL, Eriksson JG, Palotie A, Barnett JH,
Lee PH, Luciano M, Tenesa A, Davies G, Lopez LM, Hansell
NK, Medland SE, Ferrucci L, Schlessinger D, Montgomery GW,
Wright MJ, Aulchenko YS, Janssens AC, Oostra BA, Metspalu
A, Abecasis GR, Deary IJ, Raikkonen K, Bierut LJ, Martin NG,
Wray NR, van Duijn CM, Smoller JW, Penninx BW, Boomsma
DI (2011) The genetic association between personality and
major depression or bipolar disorder. A polygenic score analysis
using genome-wide association data. Transl Psychiatry 1:e50
Nadri C, Bersudsky Y, Belmaker RH, Agam G (2007) Elevated
urinary ADAM12 protein levels in lithium-treated bipolar
patients. J Neural Transm 114(4):473–477
Ovadia G, Shifman S (2011) The genetic variation of RELN
expression in schizophrenia and bipolar disorder. PLoS One
6(5):e19955
Patrick CJ, Curtin JJ, Tellegen A (2002) Development and validation
of a brief form of the multidimensional personality question-
naire. Psychol Assess 14(2):150–163
Rettew DC, Rebollo-Mesa I, Hudziak JJ, Willemsen G, Boomsma DI
(2008) Non-additive and additive genetic effects on extraversion
in 3314 Dutch adolescent twins and their parents. Behav Genet
38(3):223–233
Rhodes RE, Smith NEI (2006) Personality correlates of physical
activity: a review and meta-analysis. Br J Sports Med
40(12):958–965
Service SK, Verweij KJ, Lahti J, Congdon E, Ekelund J, Hintsanen
M, Raikkonen K, Lehtimaki T, Kahonen M, Widen E, Taanila A,
Veijola J, Heath AC, Madden PA, Montgomery GW, Sabatti C,
Jarvelin MR, Palotie A, Raitakari O, Viikari J, Martin NG,
Eriksson JG, Keltikangas-Jarvinen L, Wray NR, Freimer NB
Behav Genet (2016) 46:170–182 181
123
(2012) A genome-wide meta-analysis of association studies of
Cloninger’s Temperament Scales. Transl Psychiatry 2:e116
Sutin AR, Ferrucci L, Zonderman AB, Terracciano A (2011)
Personality and obesity across the adult life span. J Pers Soc
Psychol 101(3):579–592
Terracciano A, Lockenhoff CE, Zonderman AB, Ferrucci L, Costa PT
(2008) Personality predictors of longevity: activity, emotional
stability, and conscientiousness. Psychosom Med 70(6):621–627
Terracciano A, Sanna S, Uda M, Deiana B, Usala G, Busonero F,
Maschio A, Scally M, Patriciu N, Chen WM, Distel MA,
Slagboom EP, Boomsma DI, Villafuerte S, Sliwerska E,
Burmeister M, Amin N, Janssens ACJW, van Duijn CM,
Schlessinger D, Abecasis GR, Costa PT (2010) Genome-wide
association scan for five major dimensions of personality. Mol
Psychiatry 15(6):647–656
Terracciano A, Sutin AR, An Y, O’Brien RJ, Ferrucci L, Zonderman
AB, Resnick SM (2014) Personality and risk of Alzheimer’s
disease: new data and meta-analysis. Alzheimer’s Dement J
Alzheimer’s Assoc 10(2):179–186
Turkheimer E, Pettersson E, Horn EE (2014) A phenotypic null
hypothesis for the genetics of personality. Annu Rev Psychol
65:515–540
van den Berg SM, de Moor MH, McGue M, Pettersson E, Terracciano
A, Verweij KJ, Amin N, Derringer J, Esko T, van Grootheest G,
Hansell NK, Huffman J, Konte B, Lahti J, Luciano M, Matteson
LK, Viktorin A, Wouda J, Agrawal A, Allik J, Bierut L, Broms
U, Campbell H, Smith GD, Eriksson JG, Ferrucci L, Franke B,
Fox JP, de Geus EJ, Giegling I, Gow AJ, Grucza R, Hartmann
AM, Heath AC, Heikkila K, Iacono WG, Janzing J, Jokela M,
Kiemeney L, Lehtimaki T, Madden PA, Magnusson PK,
Northstone K, Nutile T, Ouwens KG, Palotie A, Pattie A,
Pesonen AK, Polasek O, Pulkkinen L, Pulkki-Raback L,
Raitakari OT, Realo A, Rose RJ, Ruggiero D, Seppala I, Slutske
WS, Smyth DC, Sorice R, Starr JM, Sutin AR, Tanaka T,
Verhagen J, Vermeulen S, Vuoksimaa E, Widen E, Willemsen
G, Wright MJ, Zgaga L, Rujescu D, Metspalu A, Wilson JF,
Ciullo M, Hayward C, Rudan I, Deary IJ, Raikkonen K, Arias
Vasquez A, Costa PT, Keltikangas-Jarvinen L, van Duijn CM,
Penninx BW, Krueger RF, Evans DM, Kaprio J, Pedersen NL,
Martin NG, Boomsma DI (2014) Harmonization of Neuroticism
and Extraversion phenotypes across inventories and cohorts in
the Genetics of Personality Consortium: an application of Item
Response Theory. Behav Genet 44(4):295–313
Verweij KJ, Zietsch BP, Medland SE, Gordon SD, Benyamin B,
Nyholt DR, McEvoy BP, Sullivan PF, Heath AC, Madden PA,
Henders AK, Montgomery GW, Martin NG, Wray NR (2010) A
genome-wide association study of Cloninger’s temperament
scales: implications for the evolutionary genetics of personality.
Biol Psychol 85(2):306–317
Verweij KJ, Yang J, Lahti J, Veijola J, Hintsanen M, Pulkki-Raback
L, Heinonen K, Pouta A, Pesonen AK, Widen E, Taanila A,
Isohanni M, Miettunen J, Palotie A, Penke L, Service SK, Heath
AC, Montgomery GW, Raitakari O, Kahonen M, Viikari J,
Raikkonen K, Eriksson JG, Keltikangas-Jarvinen L, Lehtimaki
T, Martin NG, Jarvelin, Visscher PM, Keller MC, Zietsch BP
(2012) Maintenance of genetic variation in human personality:
testing evolutionary models by estimating heritability due to
common causal variants and investigating the effect of distant
inbreeding. Evolution 66(10):3238–3251
Vilhjalmsson B, Yang J, Finucane HK, Gusev A, Lindstrom S, Ripke
S, Genovese G, Loh P-R, Bhatia G, Do R, Hayeck T, Won H-H,
Genomics Consortium SWGotP, Variants in Breast Cancer study
tDB, Risk of I, Kathiresan S, Pato M, Pato C, Tamimi R, Stahl E,
Zaitlen N, Pasaniuc B, Schierup M, De Jager P, Patsopoulos N,
McCarroll SA, Daly M, Purcell S, Chasman D, Neale B,
Goddard M, Visscher PM, Kraft P, Patterson NJ, Price AL
(2015) Modeling Linkage Disequilibrium Increases Accuracy of
Polygenic Risk Scores. bioRxiv. doi:10.1101/015859
Vinkhuyzen AA, Pedersen NL, Yang J, Lee SH, Magnusson PK,
Iacono WG, McGue M, Madden PA, Heath AC, Luciano M,
Payton A, Horan M, Ollier W, Pendleton N, Deary IJ,
Montgomery GW, Martin NG, Visscher PM, Wray NR (2012)
Common SNPs explain some of the variation in the personality
dimensions of neuroticism and extraversion. Transl Psychiatry
2:e102
Visscher PM, Yang J, Goddard ME (2010) A commentary on
‘Common SNPs explain a large proportion of the heritability for
human height’ by Yang et al. (2010). Twin Res Human Genet
13(6):517–524
Weiss A, Bates TC, Luciano M (2008) Happiness is a personal(ity)
thing—the genetics of personality and well-being in a represen-
tative sample. Psychol Sci 19(3):205–210
Yamagata S, Suzuki A, Ando J, Ono Y, Kijima N, Yoshimura K,
Ostendorf F, Angleitner A, Riemann R, Spinath FM, Livesley
WJ, Jang KL (2006) Is the genetic structure of human
personality universal? A cross-cultural twin study from North
America, Europe, and Asia. J Pers Soc Psychol 90(6):987–998
Yang J, Benyamin B, McEvoy BP, Gordon S, Henders AK, Nyholt
DR, Madden PA, Heath AC, Martin NG, Montgomery GW,
Goddard ME, Visscher PM (2010) Common SNPs explain a
large proportion of the heritability for human height. Nat Genet
42(7):565–569
182 Behav Genet (2016) 46:170–182
123